Cooley represented Silverback, Kirkland & Ellis advised Nextech, Inceptiv Law advised ARS on the deal.Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”) and ARS Pharmaceuticals, Inc. (“ARS”) have…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
